Barbora Weinbergerova
0000-0001-6460-2471
Masaryk University
14 papers found
Refreshing results…
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the epicovideha registry
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients
Outcome of infection with omicron SARS‐CoV ‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
Effective NPM1 plasmid standards selection for minimal/measurable residual disease monitoring in acute myeloid leukemia
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
Successful early use of anti‐SARS‐CoV‐2 monoclonal neutralizing antibodies in SARS‐CoV‐2 infected hematological patients – A Czech multicenter experience
Successful early treatment combining remdesivir with high‐titer convalescent plasma among COVID‐19‐infected hematological patients
Missing publications? Search for publications with a matching author name.